| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 4.23 | 105.3% | 2.4% |
| Total Income | 4.23 | 105.3% | 2.4% |
| Expenditure | 5.63 | 6.6% | 16.8% |
| PBT | — | ||
| Net Profit | -1.42 | 47.6% | 31.4% |
| OPM | -33.17% | 30.75pp | |
| NPM | -33.62% | 16.57pp | |
| EPS | -0.54 | 56.5% | 440.0% |
Ekso Bionics Reports Results for Nine Months Ended September 30, 2025
04 May 2026 · 4 May, 8:45 am
No detailed content available for this press release.
Informational and educational content only. Not investment advice.